Cancer Research UK Science and Innovation

We’re committing further funding towards radiobiology and radiation cancer research.      Radiobiology research is a strength of the UK that has been elevated by RadNet, our network of specialised Radiation Research Centres of Excellence, since its establishment in 2019. £24m in further funding will support seven RadNet centres over five years, enabling the continued development of an internationally leading research portfolio.     Learn more about the network  👉 https://bit.ly/3YIpOoT

We’re delighted to share the news that we've appointed Dr Simon Boulton as our first Chief Translation Advisor. As co-founder of the spin-out Artios Pharma Ltd, Simon has first-hand experience in academic translation. In this new role he will help us develop and champion our approach to innovation across Cancer Research UK and Cancer Research Horizons portfolios.   Congratulations and welcome to your new role Simon!  👉 https://bit.ly/3C0maxP

Do you have an early-stage therapeutic or validation target for children’s and young people’s cancers? #CFurther wants to hear from you. Submit your expression of interest for the chance to gain access to cutting-edge drug discovery facilities, expert support, funding and resources to advance your therapeutic asset into novel medicines. Submit your proposal by 1 November 2024 👉 https://bit.ly/3Aghvr0 Cancer Research Horizons LifeArc

Congratulations Mohamed (Soly) Ismail! Soly was awarded the 2024 Sir David Cooksey Prize in Translation for his work in Julian Downward's Oncogene Biology Laboratory to increase the potential of a platform to detect complex protein interactions by allowing it to undertake many tests at once, a process that could be transformative for identifying new cancer drugs. Read more about the award-winning research below 👇

Advancements in radiomics, deep learning and AI pathological approaches are enabling a novel method of classifying responses from rectal cancer patients to chemoradiotherapy. We spoke to Joanne Edwards from our Scotland Centre about the new project she’s co-leading that will use these advancements to enhance classification methods, integrating radiomics with other data such as clinical, pathological and genomic to inform the management of rectal cancer. This project will see researchers, surgeons and engineers collaborate to convert scan images into high-dimensional data for analysis to support clinical decision-making and new drug development. Read the interview 👉 https://bit.ly/3YM5nrr

📣 Congratulations to Professor Antonis Antoniou for winning the Don Listwin Award at our #EDxConf24.  This award recognises Antonis’ and his team’s work in advancing cancer risk prediction, which empowers informed decisions on cancer prevention and screening.  Join us in celebrating these remarkable contributions, including innovative statistical techniques for modelling cancer susceptibility, understanding cancer risks for genetically susceptible individuals, and developing cancer risk prediction tools for clinical use.  Read our Q&A: https://bit.ly/48hJVxi OHSU Knight Cancer Institute | University of Cambridge 

Congratulations to Juanita Lopez, Christina Yap and Richard Mair for their Experimental Medicine Award from our Clinical Research Committee. The team are designing a new UK-wide clinical trial to find better treatments for brain cancer. This study will test multiple medicines as treatments for people living with glioma. The Institute of Cancer Research | Cancer Research UK Cambridge Centre | Minderoo Foundation | #CRUKFunded    Learn more: https://lnkd.in/dVCfu8nX

🚨 Are you working in children’s and young people’s cancer research? Our upcoming webinar on 25 November 2024, from 3–4:30pm (GMT), will explore therapeutic discovery research. Hear from leading experts as they share their work on developing more effective, targeted treatments for children and young people affected by cancer. Plus, we’ll highlight of the newly launched international consortium, C-Further. Sign up now 👉 https://bit.ly/4gZmzAK #ExploringCYPCancers

Our #BlackLeadersinCancer programme offers Black heritage students the chance of a fully funded 4-year PhD studentship, including networking and wraparound support, at one of our seven host locations. Students will first need to apply to the programme through our partners Windsor Fellowship before applying for the studentship at your desired location. Each host location has different application open dates and deadlines. Find out more about the programme, watch recordings of insight sessions you may have missed and start the application process here: 👉 bit.ly/45AXB4f

After our recent launch of C-Further with LifeArc, we caught up with David Jenkinson, Head of Childhood Cancer Translational Challenge at LifeArc to get some context around what this consortium is, how it might work to lower financial risks and why you should get involved: https://lnkd.in/eHZgjuAi